2020Journal of HepatologyOpen access

Efficacy and tolerance of obeticholic acid in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid in real life: interim analysis of the OCARELIFE study

Vincent Leroy, Christophe Corpechot, Jérôme Dumortier, Laurent Alric, Dominique Larrey, Sébastien Dharancy, Olivier Chazouillères, Alexandra Heurgué–Berlot, Francois Boer, Aldo Trylesinski

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ursodeoxycholic acid, Obeticholic acid, Medicine, Interim, Interim analysis, Gastroenterology, Internal medicine, Clinical trial

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy and tolerance of obeticholic acid in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid in real life: interim analysis of the OCARELIFE study — Research Paper | ScholarLens